2008
DOI: 10.1016/j.jacc.2008.05.054
|View full text |Cite
|
Sign up to set email alerts
|

Elevated Plasma Fibrinogen and Diabetes Mellitus Are Associated With Lower Inhibition of Platelet Reactivity With Clopidogrel

Abstract: Elevated plasma fibrinogen (> or =375 mg/dl) in the presence of diabetes mellitus and increased BMI (> or =25 kg/m(2)) are associated with lower PI with clopidogrel in patients with CVD.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
71
1
2

Year Published

2009
2009
2016
2016

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 121 publications
(78 citation statements)
references
References 29 publications
4
71
1
2
Order By: Relevance
“…However, the relationship between hypertension and the incidence of clopidogrel resistance remains unclear. Although diabetes mellitus was previously suggested to influence the antiplatelet effects of clopidogrel [39,40] , we did not observe any correlation between CR and diabetes mellitus in our study population. In addition, sex, age, smoking, drinking or other biomedical indexes were not associated with CR in ischemic stroke patients.…”
Section: Discussioncontrasting
confidence: 94%
“…However, the relationship between hypertension and the incidence of clopidogrel resistance remains unclear. Although diabetes mellitus was previously suggested to influence the antiplatelet effects of clopidogrel [39,40] , we did not observe any correlation between CR and diabetes mellitus in our study population. In addition, sex, age, smoking, drinking or other biomedical indexes were not associated with CR in ischemic stroke patients.…”
Section: Discussioncontrasting
confidence: 94%
“…Platelet membrane proteins can be glycated. The increased binding of fibrinogen and the increased platelet aggregation observed in diabetic patients 26 can be related to glycation of the adenosine diphosphate receptors and lipids indicating that the number of Fig. 1.…”
Section: Results and Conclusionmentioning
confidence: 99%
“…These include CYP2C19 singlenucleotide polymorphisms, age, body mass index, diabetes mellitus, renal function, C-reactive protein, fibrinogen, and endothelial function. 18,[21][22][23][24][25][26] In this study, we simultaneously measured peripheral endothelial function by RHI and evaluated RPR in a population lacking CYP2C19*2 or *3 loss-offunction allele, selected specifically to avoid the effects of this gene on platelet activity. The results identified peripheral endothelial dysfunction as a significant determinant of high RPR in patients with stable CAD.…”
Section: Discussionmentioning
confidence: 99%
“…The multivariable linear regression model consisted of RHI and the variables (age, diabetes mellitus, estimated glomerular filtration rate, and Log 10 [BNP]) that had been independently shown to impact RPR in the previous studies. 18,[21][22][23][24][25][26] Each of RHI and BNP was shown as the independently associated factor for RPR (Table 2). We also analyzed the association in the 2 groups regarding the duration of clopidogrel treatment: the short-term loading group (≤7 days) and the long-term group (>7 days).…”
Section: Correlation Between Rhi and Prumentioning
confidence: 99%